Filing Details
- Accession Number:
- 0001171843-15-005296
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-24 21:56:16
- Reporting Period:
- 2015-09-22
- Filing Date:
- 2015-09-24
- Accepted Time:
- 2015-09-24 21:56:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1582313 | Xenon Pharmaceuticals Inc. | XENE | Pharmaceutical Preparations (2834) | 980661854 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1619960 | Paul Y. Goldberg | C/O Xenon Pharmaceuticals Inc 200 - 3650 Gilmore Way Burnaby A1 V5G 4W8 | Vp Of Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2015-09-22 | 411 | $5.22 | 6,514 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 198 | $9.53 | 6,316 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2015-09-22 | 2,057 | $3.21 | 8,373 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 610 | $9.53 | 7,763 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2015-09-22 | 1,028 | $3.77 | 8,791 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 305 | $9.53 | 8,486 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2015-09-22 | 5,144 | $3.07 | 13,630 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 1,525 | $9.53 | 12,105 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2015-09-22 | 6,172 | $3.56 | 18,277 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 1,829 | $9.53 | 16,448 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2015-09-22 | 3,703 | $3.52 | 20,151 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 1,098 | $9.53 | 19,053 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2015-09-22 | 3,115 | $3.73 | 22,168 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 923 | $9.53 | 21,245 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2015-09-22 | 7,973 | $2.68 | 29,218 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 1,687 | $9.53 | 27,531 | No | 4 | F | Direct | |
| Common Shares | Acquisiton | 2015-09-22 | 785 | $2.68 | 28,316 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2015-09-22 | 167 | $9.53 | 28,149 | No | 4 | F | Direct | |
| Common Shares | Disposition | 2015-09-22 | 6,149 | $9.33 | 22,000 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2015-09-23 | 4,000 | $9.02 | 18,000 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2015-09-24 | 12,000 | $8.60 | 6,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 411 | $0.00 | 411 | $5.22 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 2,057 | $0.00 | 2,057 | $3.21 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 1,028 | $0.00 | 1,028 | $3.77 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 5,144 | $0.00 | 5,144 | $3.07 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 6,172 | $0.00 | 6,172 | $3.56 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 3,703 | $0.00 | 3,703 | $3.52 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 3,115 | $0.00 | 3,115 | $3.73 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 7,973 | $0.00 | 7,973 | $2.68 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2015-09-22 | 785 | $0.00 | 785 | $2.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-12-31 | No | 4 | M | Direct | |
| 0 | 2016-12-31 | No | 4 | M | Direct | |
| 0 | 2017-12-31 | No | 4 | M | Direct | |
| 0 | 2018-12-31 | No | 4 | M | Direct | |
| 0 | 2019-12-31 | No | 4 | M | Direct | |
| 0 | 2020-07-01 | No | 4 | M | Direct | |
| 1,000 | 2020-12-01 | No | 4 | M | Direct | |
| 4,372 | 2022-12-31 | No | 4 | M | Direct | |
| 243 | 2022-12-31 | No | 4 | M | Direct |
Footnotes
- The exercise price was converted from $6.07 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.
- Represents the closing price of the Company's common shares on September 21, 2015, converted to a Canadian dollar amount for purposes of net settlement calculations.
- The exercise price was converted from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.
- The exercise price was converted from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.15 to $9.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $8.50 to $8.715, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The shares subject to the option fully vested on December 31, 2009.
- The shares subject to the option fully vested on December 31, 2010.
- The shares subject to the option fully vested on December 31, 2011.
- The shares subject to the option fully vested on December 31, 2012.
- The shares subject to the option fully vested on December 31, 2013.
- The shares subject to the option fully vested on June 30, 2014.
- The shares subject to the option fully vested on November 30, 2014.
- 25% of the shares subject to the Option vested on the one year anniversary of January 1, 2013 (the "Vesting Commencement Date") and thereafter 1/48th of the shares subject to the Option vest on each monthly anniversary of the Vesting Commencement Date.
- One-third of the shares subject to the Option vested on January 1, 2013 (the "Vesting Commencement Date") and the remaining two-thirds of the shares subject to the Option vest in equal monthly installments on each monthly anniversary of the Vesting Commencement Date over the following four years.
Billionaire Hedge Funds
